Director, Office of Clinical Pharmacology
US Food and Drug Administration
Issam Zineh is Director of the Office of Clinical Pharmacology (OCP) at the U.S Food and Drug Administration (FDA). He has held various leadership positions at FDA including Associate Director for Genomics in OCP (2008-2012) and Co-Director of the CDER Biomarker Qualification Program (2009-2015). Dr. Zineh received his PharmD from Northeastern University and completed his residency at Duke University Medical Center. He completed a fellowship in cardiovascular pharmacogenomics at the University of Florida (UF) where he also obtained his MPH in Health Policy and Management. Dr. Zineh was formerly on faculty at the UF Colleges of Pharmacy and Medicine and Associate Director of the UF Center for Pharmacogenomics. He is a recognized expert in the fields of drug development and evaluation, clinical pharmacology, pharmacotherapy, and precision medicine. As Director of OCP, Dr. Zineh leads a staff of over 240 regulatory, research, program/project management, and administrative staff in FDA’s efforts to enhance drug development and promote regulatory innovation through clinical pharmacology and experimental medicine.
Disclosure information not submitted.
Monday, January 10, 2022
10:00 AM – 10:30 AM ET
Thursday, January 13, 2022
4:15 PM – 5:15 PM ET
Friday, January 14, 2022
2:15 PM – 2:20 PM ET
Wednesday, March 16, 2022
12:30 PM – 1:30 PM ET
Wednesday, March 16, 2022
6:15 PM – 7:15 PM ET
Thursday, March 17, 2022
11:30 AM – 12:00 PM ET
Thursday, March 17, 2022
12:00 PM – 12:15 PM ET
Thursday, March 17, 2022
2:30 PM – 3:30 PM ET
Thursday, March 17, 2022
3:45 PM – 4:15 PM ET
Friday, March 18, 2022
4:45 PM – 5:15 PM ET
Friday, March 18, 2022
6:00 PM – 6:15 PM ET
.png)